Description
Using our intelligently designed and intuitive dataset, you can quickly understand how Resmed (RMD) is lobbying the U.S. government, how much they’re spending on it, and most importantly – the bills and specific issues on which they lobby.
Gain an informational edge with our Lobbying Data Intelligence. Perform analysis by company, lobbyist, lobbying firm, government agency, or issue.
For lobbying firms: understand your competitors. Understand who is registering with who. Gain insight on quarterly reports and specific issues other firms are lobbying on.
Our lobbying data is collected and aggregated from the U.S. Senate Office of Public Records from 1999-present and is updated on a regular basis. We utilize advanced data science techniques to ensure accurate data points are collected and ingested, match similar entities across time, and tickerize publicly traded companies that lobby.
Our comprehensive and advanced lobbying database is completed with all the information you need, with more than 1.6 million lobbying contracts ready-for-analysis. We include detailed information on all aspects of federal lobbying, including the following fascinating attributes, among much more:
1. Clients: The publicly traded company, privately owned company, interest group, NGO, or state or local government that employs or retains a lobbyist or lobbying firm.
2. Registrants (Lobbying Firms): Either the name of the lobbying firm hired by the client, or the name of the client if the client employs in-house lobbyists.
3. Lobbyists: The names and past government work experience of the individual lobbyists working on a lobbying contract. 3. General Issues: The general issues for which clients lobby on (ex: ENV – Environment, TOB – Tobacco, FAM – Family Issues/Abortion).
4. Specific Issues: A long text description of the exact bills and specific issues for which clients lobby on.
5. Bills Lobbied On: The exact congressional bills and public/private laws lobbied on, parsed from lobbying report specific issues (ex: H.R. 2347, S. 1117, Tax Cuts and Jobs Act).
6. Agencies Lobbied: The names of one or more of 250+ government agencies lobbied on in the contract (ex: White House, FDA, DOD).
7. Foreign Entities: The names and origin countries of entities affiliated with the client (ex: BNP Paribas: France).
Gain access to our highly unique and actionable U.S. lobbying database. Further information on LobbyingData.com and our alternative datasets and database can be found on our website, or by contacting [email protected].
Frequently Asked Questions
What is Resmed (RMD) lobbying for?
Summary of Lobbying Data:
– Lobbying Firms: Dla Piper Llp (Us), Akin Gump Strauss Hauer & Feld
– General Issues: Medicare/Medicaid, Health Issues
– Specific Issues: Trade issues, supply chain issues, product shortages in medical devices, telemonitoring, ventilator coverage policy, DMEPOS, competitive bidding program, SMART Act, CARES Act, digital health regulation and reimbursement, data privacy, respiratory care.
– Government Agencies: Senate, Department of Health & Human Services (HHS), House of Representatives.
One could infer that Resmed is lobbying on healthcare-related issues such as Medicare/Medicaid and Health Issues, as they are a medical equipment manufacturer providing products and services related to respiratory care. They are likely lobbying on trade and supply chain issues because they may depend on importing certain components for their medical devices. The effort to address product shortages in medical devices and supply chain issues may also be related to the COVID-19 pandemic. The digital health regulation and reimbursement issues indicate that Resmed is likely looking to expand their offerings in the digital health space, potentially for remote monitoring of patients with respiratory issues. Overall, it appears that Resmed is lobbying in order to advocate for policies that benefit their business, as well as to shape regulations in the healthcare industry.
